Hirschberg-Grosssachsen, Germany

Hans P Wolff


Average Co-Inventor Count = 3.8

ph-index = 5

Forward Citations = 99(Granted Patents)


Location History:

  • Mannheim, DE (1979)
  • Hirschberg-Grosssachsen, DE (1983 - 1990)
  • Hirschberg-Grossachsen, DE (1981 - 1992)

Company Filing History:


Years Active: 1979-1992

Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovations of Hans P. Wolff

Introduction

Hans P. Wolff is a notable inventor based in Hirschberg-Grosssachsen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on carboxylic acid derivatives. With a total of 9 patents to his name, Wolff's inventions have the potential to impact the treatment of various metabolic diseases.

Latest Patents

Wolff's latest patents focus on carboxylic acid derivatives and pharmaceutical compositions containing these compounds. The specific formula involves various substituents, including alkoxy, alkylthio, and aryl groups, which are designed to enhance the efficacy of the compounds in treating metabolic diseases. These innovations represent a significant advancement in pharmaceutical chemistry.

Career Highlights

Throughout his career, Hans P. Wolff has been associated with Boehringer Mannheim GmbH, a leading company in the pharmaceutical industry. His work has not only contributed to the company's portfolio but has also advanced the field of medicinal chemistry. His dedication to research and development has established him as a respected figure in his field.

Collaborations

Wolff has collaborated with esteemed colleagues such as Ernst-Christian Witte and Max Thiel. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, further enhancing the impact of their collective work.

Conclusion

Hans P. Wolff's contributions to the field of pharmaceuticals through his innovative patents on carboxylic acid derivatives highlight his importance as an inventor. His work continues to pave the way for advancements in the treatment of metabolic diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…